Drug Discovery & Pharmaceuticals

RSS
Unlocking hidden soil microbes for new antibiotics

Unlocking hidden soil microbes for new antibiotics

Novel method accurately identifies therapeutic antibodies to treat infectious diseases

Novel method accurately identifies therapeutic antibodies to treat infectious diseases

Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology

Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology

BioDlink expands ecosystem alliance to empower biotech innovators worldwide

BioDlink expands ecosystem alliance to empower biotech innovators worldwide

Breakthrough technology enables faster and cheaper antibody analysis

Breakthrough technology enables faster and cheaper antibody analysis

Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions

Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

TRIMTECH Therapeutics establishes Scientific Advisory Board

TRIMTECH Therapeutics establishes Scientific Advisory Board

Generative AI creates life-saving antibiotics from scratch

Generative AI creates life-saving antibiotics from scratch

Aptamer signs therapeutic development agreement with Invizius

Aptamer signs therapeutic development agreement with Invizius

New reaction approach expands possibilities for drug discovery building blocks

New reaction approach expands possibilities for drug discovery building blocks

Aptamer Group introduces novel biomarker discovery service

Aptamer Group introduces novel biomarker discovery service

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Indole chemistry breakthrough opens doors for more effective drug synthesis

Indole chemistry breakthrough opens doors for more effective drug synthesis

Balancing speed and selectivity is key for designing effective targeted covalent inhibitors

Balancing speed and selectivity is key for designing effective targeted covalent inhibitors

University of Vienna team develops method to measure molecular charges

University of Vienna team develops method to measure molecular charges

Nanodroplet array revolutionizes search for new drugs

Nanodroplet array revolutionizes search for new drugs

AI predicts designer drug structures for improved detection

AI predicts designer drug structures for improved detection

Artificial intelligence enables discovery of novel compounds to fight drug-resistant bacteria

Artificial intelligence enables discovery of novel compounds to fight drug-resistant bacteria

Camena Bioscience and Constructive Bio join synthetic biology collaboration to develop plant genomics

Camena Bioscience and Constructive Bio join synthetic biology collaboration to develop plant genomics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.